This is a preview of subscription content, log in via an institution to check access.
Reference
European Commission. Introduction of fees to be charged by the EMA for pharmacovigilance - summary of the replies to the public consultation paper. Internet Document : [11 pages], 29 Nov 2012. Available from: URL: http://ec.europa.eu
Additional information
* small and medium-sized enterprises
Rights and permissions
About this article
Cite this article
Stakeholders say EMA's proposed PV fees are too high. PharmacoEconomics & Outcomes News 668, 10 (2012). https://doi.org/10.1007/s40274-012-0034-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-012-0034-6